Safe Use of Ursodeoxycholic Acid in the Treatment of Dyspeptic Symptoms in Patients with Chronic Active Hepatitis: A Double-Blind Controlled Trial

Journal of International Medical Research

Volumn 10, Issue 4, 1982, Pages 278-282

  Blanco, C Del Vecchio ^a   Caporaso, N ^b   Gentile, S ^b   Rinaldi, M ^b   Pucci, R ^b  

^a Insegnamento di Malattie dell'Apparato digerente ^*  (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; URSODEOXYCHOLIC ACID;

BILE DUCT; CHRONIC ACTIVE HEPATITIS; CHRONIC HEPATITIS; CONTROLLED STUDY; DIGESTIVE SYSTEM; DRUG COMPARISON; DYSPEPSIA; LIVER; MAJOR CLINICAL STUDY; THERAPY;

ADULT; DEOXYCHOLIC ACID; DOUBLE-BLIND METHOD; DYSPEPSIA; FEMALE; HEPATITIS B; HUMANS; LIVER FUNCTION TESTS; MALE; RANDOM ALLOCATION; URSODEOXYCHOLIC ACID;

EID: 0019988597     PISSN: 03000605     EISSN: 14732300     Source Type: Journal    
DOI: 10.1177/030006058201000416     Document Type: Article

References (16)

1. Armitage P (1974) Statistical methods in medical research. Blackwell Scientific Publ., Oxford.
2. Baggenstoss A H Soloway R D Summerskill W H J Elveback L R Schoenfield L J (1972) Chronic active liver disease. The range of histologic lesions, their response to treatment and evolution. Human Pathology 4, 183.
3. Coltorti M Del Vecchio Blanco C Caporaso N Ambrogio G Krauss R Russo Mattera D (1978) Aspetti e problemi clinici delle epatiti croniche nel nostro paese. Rel Convegno su “Epatiti virali e meningoencefaliti” Napoli 23-24 Novembre 1978. Atti Pacini Ed. Pisa, p 5.
4. Coltorti M Del Vecchio Blanco C Caporaso N De Carlo R (1980) Relationship between HBCAb and HBSAg or HBSAb in chronic hepatitis and healthy carriers in Campania (S. Italy). Italian Journal of Gastroenterology 12, 14.
5. Cook G C Mulligan R Sherlock S (1971) Controlled prospective trial of corticosteroid therapy in active chronic hepatitis. Quarterly Journal of Medicine 40, 159.
6. Fedorowski T Salen G Zaki G F Shefer S Mosbach EH (1978) Comparative effects of ursodeoxycholic acid and chenodeoxycholic acid in the rhesus monkey. Biochemical and ultrastructural studies. Gastroenterology 74, 75.
7. Frigerio G (1979) Ursodeoxycholic acid (UDCA) in the treatment of dyspepsia: Report of a multicentric controlled trial. Current Therapeutic Research 26, 214.
8. Gentile S Foglia F Grignl N Coltorti M (1980) Eliminazione plasmatica di rifamicina-SV in epatopatie croniche e nella sindrome di Gilbert. Riforma Medica 95, 7.
9. GIRC Inter-Hospital Clinical Research Group (1979) Effect of ursodeoxycholic acid (UDCA) on dyspepsia in patients with gallstones or other biliary tract anomalies. Current Therapeutic Research 26, 230.
10. GIRC Inter-Hospital Clinical Research Group (1981) Treatment of radiolucent gallstones with CDCA or UDCA. A multicenter trial. Digestion, 22.
11. Koretz R L Lewin K J Higgins J Fagen N D Gitnick G L (1980) Chronic active hepatitis. Who meets treatments criteria? Dig. Dis. Scie. 25, 695.
12. Leuschner V Leuschner M Hubner K (1981) Gallstone dissolution in patients with chronic active hepatitis. Abstr. from AGA, New York City, May 18-20.
13. Murray-Lyon I M Stern R B Williams R (1973) Controlled trial of prednisolone and azathioprine in active chronic hepatitis. Lancet 1, 735.
14. Plotz P H (1975) Asymptomatic chronic hepatitis. Gastroenterology 68, 1629.
15. Schalm S W Summerskill W H J Gitnick G L Elveback L R (1976) Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis B s Antigen. Gut 17, 781.
16. Soloway R D Summerskill W H J Baggenstoss A H Geall M G Gitnick G L Elvebach L R Schoenfield L J (1972) Clinical, biological and histological remission of severe chronic active liver disease. A controlled study of treatments and early prognosis. Gastroenterology 63, 820.